
Three Stocks Built for Disrupting the Big Pharma Hegemony (TIVC, EMED, ZBH, NVCR, MDT, ZYXI, ECOR, ISRG)
The number one fact in play right now for investors is risk aversion. According to Bank of America strategists, professional money managers are currently sitting











